Company Filing History:
Years Active: 2025
Title: Jinfeng Zeng: Innovator in Blood Group Genotyping
Introduction
Jinfeng Zeng is a notable inventor based in Guangdong, China. He has made significant contributions to the field of blood group genotyping, particularly through his innovative methods and kits that enhance detection efficiency.
Latest Patents
Jinfeng Zeng holds a patent for a "Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)." This invention provides a comprehensive approach to genotyping by utilizing multiplex PCR capture primer sets and amplification reaction conditions designed for the Illumina platform. The method allows for the simultaneous detection of full-length coding regions and spliced flanking regions of 25 blood group genes across 17 RBC blood group systems. This advancement enables rapid genotyping and addresses limitations in existing blood group gene detection technologies.
Career Highlights
Jinfeng Zeng is associated with the Shenzhen Blood Center, where he applies his expertise in blood group genotyping. His work has led to high-throughput sequencing methods that offer high detection efficiency at a low average cost. His innovative approach also allows for the detection of both known and unknown mutation sites, resulting in comprehensive and accurate detection outcomes.
Collaborations
Jinfeng collaborates with talented coworkers, including Shuang Liang and Yanlian Liang, who contribute to the research and development efforts at the Shenzhen Blood Center.
Conclusion
Jinfeng Zeng's contributions to blood group genotyping through his patented methods and kits represent a significant advancement in the field. His work not only enhances detection efficiency but also provides a more comprehensive understanding of blood group genetics.